The novel coronavirus COVID-19 uses the SARS-coronavirus receptor ACE2 and TMPRSS2 a cellular protease for entry into target cells
The highly pathogenic coronavirus, COVID-19, emerges in China in 2019, and its rapid national and international spread creates a global health emergency. Coronaviruses use their spike proteins to select and…